The detection of carcinoembryonic antigen (CEA) in bile and duodenal fluid may lead to the detection of earlier LM,18 and the discovery of new markers is expected to bring hope for the treatment of CRC. This evidence concerns the gene CEACAM5 and colorectal carcinoma.